Chemical Name: N-tert-Butyl-6,7-dichloro-3-methylsulfonylquinoxalin-2-amine. Alternate Names: 6,7-Dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline
Gasdermin D agonist/GLP-1 agonist
Molekulargewicht:
348.20
Reinheit:
98% by HPLC , NMR (Conforms)
Formulierung:
Yellow solid
CAS Nummer:
[281209-71-0]
Formel:
C13H15Cl2N3O2S
Anwendungsbeschreibung:
DMB is a small molecule glucagon-like peptide 1 (GLP-1) ago-allosteric modulator and agonist (EC50 = 101 nM).1 It significantly stimulated insulin secretion in BRIN-BD11 cells and decreased overall glucose excursion in mice.2 DMB is a direct and selective gasdermin D (GSDMD) agonist that activates GSDMD pore formation and pyroptosis without cleaving GSDMD (EC50 = 700 nM).3 It induced pyroptosis in mouse cancer cell lines and induced tumor regression and enhanced antitumor immunity. DMB-treated tumor cells acted as a tumor vaccine in mice indicating that DMB can trigger immunogenic cell death that provides protective antitumor immunity.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten